TLR9 and rheumatoid arthritis: Healthy DCs stimulated with serum from RA patients were treated with hydroxychloroquine, what led to lower expression of activation markers (i.e., CD86, CXCR4) and lower IFN-α secretion due to downregulation of TLR9 [27].